CEF20, Cytomegalovirus, CMV pp65 (495-503) – 1 mg

Overview

CEF20, Cytomegalovirus, CMV pp65 (495-503) is a highly specific HLA-A*0201-restricted epitope derived from the Cytomegalovirus pp65 protein. This potent peptide plays a critical role in immune response research and vaccine development by helping to identify and track Cytomegalovirus infections. As you explore the various applications in your research, you’ll find this peptide to be an indispensable tool.

Key Features

• High purity and quality, ensuring reliable results
• HLA-A*0201-restricted, making it suitable for specific immune response studies
• Ideal for use in assays related to Cytomegalovirus
• Supports vaccine development and therapeutic research
• Available in a convenient 1 mg package

Specifications

FAQ

What are the potential applications of CEF20?

CEF20 can be utilized in various applications including immunological studies, vaccine development, and therapeutic research focused on Cytomegalovirus infections.

How should I store CEF20?

For optimal stability and effectiveness, store CEF20 at -20°C, and avoid repeated freeze-thaw cycles.

Is CEF20 suitable for in vivo studies?

CEF20 is primarily designed for in vitro research. If you plan to use it in vivo, please ensure thorough validation for your specific applications.

If you’re looking for high-quality peptides, you might also be interested in our PKG Substrate or Autocamtide-2 for various research needs. Discover more peptides in our Peptides category and enhance your research capabilities today.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled